|
TTC30B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.983100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.983200E-04 |
| Normal-vs-Stage2 |
3.152100E-02 |
| Normal-vs-Stage3 |
5.720400E-01 |
| Normal-vs-Stage4 |
4.237400E-01 |
| Stage1-vs-Stage2 |
5.398200E-01 |
| Stage1-vs-Stage3 |
3.439200E-01 |
| Stage1-vs-Stage4 |
5.421800E-01 |
| Stage2-vs-Stage3 |
5.718000E-01 |
| Stage2-vs-Stage4 |
7.475400E-01 |
| Stage3-vs-Stage4 |
8.622800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.542200E-03 |
| Normal-vs-AfricanAmerican |
2.424600E-03 |
| Normal-vs-Asian |
1.714370E-02 |
| Caucasian-vs-AfricanAmerican |
6.738000E-01 |
| Caucasian-vs-Asian |
7.073000E-01 |
| AfricanAmerican-vs-Asian |
7.506600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87809999996347E-06 |
| Normal-vs-Female |
9.952600E-01 |
| Male-vs-Female |
3.122400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.776010E-01 |
| Normal-vs-Extreme_Weight |
4.35400000000641E-05 |
| Normal-vs-Obese |
2.122800E-03 |
| Normal-vs-Extreme_Obese |
1.650580E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.092800E-01 |
| Normal_Weight-vs-Obese |
7.025600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.624400E-01 |
| Extreme_Weight-vs-Obese |
1.385610E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.998400E-01 |
| Obese-vs-Extreme_Obese |
9.684200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.297700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.025820E-01 |
| Normal-vs-Age(61-80Yrs) |
2.10869999999197E-05 |
| Normal-vs-Age(81-100Yrs) |
8.789600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.001800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.954640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.874400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.703960E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.328000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.886400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.2692999999907E-05 |
| Normal-VS-Type2 PRCC |
9.105700E-02 |
| Normal-VS-KIRP CIMP |
6.861400E-03 |
| Normal-VS-Unclassified PRCC |
6.770800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.493200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.271200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.335300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.468400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.650200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.683010E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14179999999953E-05 |
| Normal-vs-N1 |
5.517000E-01 |
| Normal-vs-N2 |
3.377800E-02 |
| N0-vs-N1 |
4.086500E-02 |
| N0-vs-N2 |
9.941200E-01 |
| N1-vs-N2 |
5.994200E-02 |
|
|
